Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Stockholders Equity of -$261.83 million for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$261.83M | +13.1% |
| 2024 | -$301.33M | +13.0% |
| 2023 | -$346.30M | -153.1% |
| 2022 | $652.38M | +7.7% |
| 2021 | $605.91M | +867.3% |
| 2020 | $62.64M | +167.2% |
| 2019 | -$93.25M | +52.5% |
| 2018 | -$196.37M | -2094.0% |
| 2017 | $9.85M | -85.2% |
| 2016 | $66.72M | -29.9% |
| 2015 | $95.12M | +7.4% |
| 2014 | $88.55M | +131.7% |
| 2013 | $38.23M | -73.5% |
| 2012 | $144.05M | +31.1% |
| 2011 | $109.86M | -31.1% |
| 2010 | $159.55M | +153.5% |
| 2009 | -$298.34M | -29.5% |
| 2008 | -$230.41M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$264.16M | +15.2% | +14.3% |
| June 30, 2025 | -$308.16M | +4.2% | +7.8% |
| March 31, 2025 | -$334.05M | -1.1% | -10.9% |
| December 31, 2024 | -$301.33M | +13.0% | +3.2% |
| September 30, 2024 | -$311.33M | +3.7% | +3.2% |
| June 30, 2024 | -$321.73M | +6.9% | +2.7% |
| March 31, 2024 | -$330.52M | -146.8% | +4.6% |
| December 31, 2023 | -$346.30M | -153.1% | -7.1% |
- IRONWOOD PHARMACEUTICALS INC showed an increase of +13.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, IRONWOOD PHARMACEUTICALS INC’s stockholders equity has declined by 13.6% (from -$230.41 million to -$261.83 million).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: